Stevanato Group Spa (STVN)

NYSE · Healthcare · Medical Instruments & Supplies · Italy

Stevanato Group Spa is a mid cap company (market value between $2 billion and $10 billion) in the Medical Instruments & Supplies industry.

Intrinsic value, DCF valuation, financial health and value investing analysis for the Stevanato Group Spa stock.

Our verdict on STVN

Fairly valued: intrinsic value $15.24 per share, market price $15.25, margin of safety -0.0% (as of 2026-11-17).

Discounting its cash flows at 9.0% (average of 2 methods) values the shares at $15.24; the price of $15.25 sits right on that value.

ETFs with the most weight in STVN

6 more funds hold it; the full list is part of the paid plan.

More on STVN

Peers in Medical Instruments & Supplies

All 52 Medical Instruments & Supplies stocks

Cheaper than STVN in Medical Instruments & Supplies

Is STVN undervalued or overvalued?

STVN is fairly valued (as of the 2026-11-17 close). Discounting its cash flows at 9.0% (average of 2 methods) values the shares at $15.24; the price of $15.25 sits right on that value.

What is the intrinsic value of STVN?

$15.24 per share (as of the 2026-11-17 close), against a market price of $15.25. That is a margin of safety of -0.0%. The value is the average of the 2 valuation methods that apply to this company, recomputed every night after the US close.